admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelic Research Bulletin: April 2023

Terran Biosciences announces publication of PCT patent application covering novel non-hallucinogenic...

Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001

Psychedelic Bulletin #137: Oregon Approves First Psilocybin Service Centre; AMA Approves...

FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph...

MIND CURE AND LNG ENERGY GROUP ENTER INTO ARRANGEMENT AGREEMENT WITH...

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical...

Algernon Pharmaceuticals Announces Closing of Rights Offering

Psychedelics Weekly – Psychedelics and Sports, The Risks of Over-Regulation, and...

1...686970...218 Page 69 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin